Diversified Tracked since Q3 FY26 - Q3 FY26

Anthem Biosciences Limited

Compare with...

ANTHEM

Latest quarter Q3 FY26

Revenue ₹423 Cr

Management credibility Building

Promise tracking available after 2+ quarters of coverage.

Latest signal bullish medium

Anthem Biosciences reported Q3 FY26 consolidated revenue of 423 crore and EBITDA of 191 crore (41.8% margin), with PA...

Quarterly Earnings Timeline

Financial verification status, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q3 FY26 15 Jan 2026

Revenue ₹423 Cr

Anthem Biosciences reported Q3 FY26 consolidated revenue of 423 crore and EBITDA of 191 crore (41.8% margin), with PAT at 93 crore (20.3% margin).